Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related event

Noah M. Hahn, Constantin T. Yiannoutsos, Kristina Kirkpatrick, Jaya Sharma, Christopher J. Sweeney

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related event'. Together they form a unique fingerprint.

Medicine & Life Sciences